Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Coffee beans contain powerful antioxidants. Here's what the research says about coffee's impact on heart health, brain health, weight loss and mood.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

As we have entered into the new year 2025, here's a recap of 2024's economy and healthcare with key areas to look in global ...

A healthcare worker holds weight-loss drug Ozempic. In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers ...

In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers unprecedented hope. Drugs like semaglutide (Wegovy ...